XSC
DCOY

X-Square Capital’s Decoy Therapeutics DCOY Stock Holding History

X-Square Capital’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$17K – 157
2022
Q3 		$17K Hold
2
– – 0.01% 146
2022
Q2 		$19K Sell
2
-1
-33% -$8.63K 0.01% 152
2022
Q1 		$39K Hold
3
– – 0.02% 150
2021
Q4 		$48K Hold
3
– – 0.02% 146
2021
Q3 		$103K Hold
3
– – 0.05% 150
2021
Q2 		$106K Sell
3
-2
-40% -$89K 0.05% 134
2021
Q1 		$245K Buy
5
+3
+150% +$172K 0.11% 106
2020
Q4 		$53K Buy
+2
New +$58.6K 0.03% 105

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return